JANET BILAFER-STEINER: Open Payments
NPI 1457875015 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$521 in 20 payments from 9 companies in 2025. Trend: 2023 $507 · 2024 $636 · 2025 $521
Food & beverage: $521
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $164 |
| Lundbeck LLC | 4 | $124 |
| Boston Scientific Corporation | 2 | $49 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| Amgen Inc. | 2 | $41 |
| Exact Sciences Corporation | 1 | $28 |
| Lilly USA, LLC | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $23 |
Products named: REXULTI, UBRELVY, WATCHMAN Access System, QULIPTA, OTEZLA, The Cologuard Plus Collection Kit, MOUNJARO, NEFFY.
Industry payments across CA — which companies pay providers there.
